Tendersinfo keep you informed about the latest events in the national and international Procurement Industry. Procurement News provides in-depth coverage of the procurement industry, including contract awards, contract additions, new contract wins, mergers and acquisitions. Tendersinfo through its tender news section provides an update on all domestic and global tendering opportunities, invitation to bid & trade leads.
United States : Symbio Signs Five-Year Agreement for OmniComms TrialMaster EDC
Publish Date : 15-Jul-2019
Symbio LLC, a client-focused, full-service clinical research organization (CRO), has signed a five-year contract with OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology. Under the agreement, Symbio will use OmniComms TrialMaster version 5 to develop and manage clinical study databases.
With TrialMaster, we have the ability to build customized clinical study databases in-house on behalf of our clients by leveraging the extensive experience of our data management team,said Tom McGuire, director of Business Administration and IT at Symbio. TrialMaster provides us with the flexibility to quickly deploy, make easy updates and manage the entire process from design, validation and deployment, thus providing both cost savings and reduced timeline benefits to our clients.
Additonally, in 2018, Symbio launched its European operations to support clients with global trials. With the opening of that division, OmniComms data center in Europe became a major factor in the selection of TrialMaster. Symbio cited the stability and excellent performance of OmniComms EDC technology, TrialMasters randomization capability, and the ability to create submission-ready CRFs, ad hoc reports and customized reports to address sponsors needs and requests as contributing factors to its decision.
We are honored and thrilled that the Symbio management team has selected OmniComms TrialMaster platform with its advanced EDC and eSource technology to enhance the services provided to their Sponsor clients, said Kuno van der Post, Ph.D., chief commercial officer, OmniComm Systems. To have another key global CRO choose TrialMaster because of the very modern user interface, reliability and fast study build capability is very rewarding.
